Home Sustained false-positive results for hepatitis A virus immunoglobulin M: A case report and literature review
Article Open Access

Sustained false-positive results for hepatitis A virus immunoglobulin M: A case report and literature review

  • Youwen Tan EMAIL logo and Li Chen
Published/Copyright: September 7, 2021

Abstract

Hepatitis A virus immunoglobulin M (HAV-IgM) is often used to diagnose acute hepatitis A virus (HAV) infection serologically. However, false-positive test results can interfere with the diagnosis. A 56-year-old woman was readmitted to the hospital owing to abnormal liver function tests for the last 18 months. She had been diagnosed with acute HAV and was hospitalized in isolation based on a positive HAV-IgM test 18 months ago. Regular follow-up after discharge showed abnormal liver function and an elevated level of antinuclear antibodies and immunoglobulin G. For the last 15 days, the patient had fatigue, decreased appetite, and yellow urine, signaling recrudescence. Liver function tests were also abnormal. Liver biopsy revealed histological changes consistent with typical autoimmune hepatitis. After 2 months of methylprednisolone treatment, liver function returned to normal, and HAV-IgM turned negative. The diagnosis of acute HAV in nonendemic areas requires a comprehensive analysis of epidemic history, clinical characteristics, etiology, etc.

1 Introduction

Immunoglobulin M (IgM) is a marker for acute viral infection and has definitive clinical value. Therefore, physicians depend on the serum marker for the diagnosis of active infection. However, an increased number of false-positive test results can lead to misdiagnosis and incorrect treatment. Relying solely on this test result further compounds the problem. Many healthcare professionals are still unaware of this issue. False-positive IgM results can occur with any pathogen. We report a case of HAV-IgM with persistently abnormal liver function tests that lasted for 18 months. The patient was incorrectly diagnosed with acute hepatitis A and, finally, with autoimmune hepatitis (AIH).

2 Case report

A 56-year-old woman was readmitted to the hospital with abnormal liver function tests, persisting for the last 18 months. Her hepatic markers were as follows, tested 18 months ago: alanine aminotransferase (ALT) 113 U/L, aspartate aminotransferase (AST) 104 U/L, alkaline phosphatase (ALP) 124 U/L, and glutamate aminotransferase (GGT) 78 U/L. This was attributed to a positive HAV-IgM (ELISA, OD value of attributed absorbance ≥2.1, determined to be positive). She was diagnosed with acute hepatitis A and hospitalized in isolation for treatment. Abnormal symptoms, such as fever, fatigue, abdominal pain, or yellow urine, were not observed. She was treated with glutathione 0.9 g and glycyrrhetinic acid 150 mg/day for 45 days. The liver function recovered, and the markers were as follows: ALT 56 U/L, AST 43 U/L, ALP 109 U/L, and GGT 65 U/L. However, HAV-IgM was still positive. During this time, anti-nuclear antibodies (ANA) 47 U/L (normal <10 U/L) were also detected. Tests for antimitochondrial antibodies (AMAs) and anti-liver kidney microsomal (LKM) antibodies, and anti-smooth muscle antibodies (SMAs) were negative. The immunoglobulin G (IgG) level was 18.3 g/L (normal range 6.2–16.1 g/L) and the IgM level was 2.71 g/L (normal range 0.98–2.04 g/L). Following discharge, regular monthly reexamination showed abnormal liver function with repeated fluctuations (Figure 1). The patient developed fatigue, decreased appetite, and yellow urine for 15 days, thus indicating recrudescence. Liver function tests showed abnormal results [total bilirubin (TBIL) 43 mol/L, ALT 452 U/L, AST 254 U/L, ALP 175 U/L, GGT95 U/L]. Further testing revealed the ANA level of 102 U/L, IgG 26.3 g/L, IgM 2.71 g/L, and IgA 5.32 g/L (normal range: 0.76–3.9 g/L). The analysis of a liver biopsy specimen revealed histological changes consistent with typical autoimmune hepatitis. There was moderate to severe interfacial inflammation, numerous lympho-plasma cell infiltrates, lymphocytic penetration, and rosette-like hepatocytes (Figure 2). HAV-IgM was positive. To rule out the possibility of HAV infection, a reverse transcription-polymerase chain reaction (RT-PCR) was conducted to detect HAV RNA in the serum. The analysis of the current samples, as well as those from a year ago, was found to be negative. Clinical diagnosis of AIH was made with a false-positive HAV-IgM. Methylprednisolone 32 mg/day was administered, which was tapered to 20 mg/day after 1 month. The liver function tests, done daily, returned to normal after 2 months, following which, methylprednisolone was further tapered to 8 mg/day as a maintenance treatment. On reexamination, the patient was negative for HAV-IgM and HAV RNA. The tests for Epstein-Barr virus (EBV), cytomegalovirus (CMV), herpes simplex virus (HSV), varicella-zoster virus, and adenovirus were negative. There was also no drug-induced liver injury or history of alcohol addiction.

Figure 1 
               Changes in the liver function and immunological indexes (LB: liver biopsy; MP: methyl prednisolone).
Figure 1

Changes in the liver function and immunological indexes (LB: liver biopsy; MP: methyl prednisolone).

Figure 2 
               Pathological features of the liver (hematoxylin-eosin staining). (a) Severe interfacial inflammation (thick arrow), ×100 and (b) lympho-plasma cell infiltration (thick arrow), lymphocytes penetrate into the hepatocytes (thin arrow), and rose cluster hepatocytes (arrow), ×200.
Figure 2

Pathological features of the liver (hematoxylin-eosin staining). (a) Severe interfacial inflammation (thick arrow), ×100 and (b) lympho-plasma cell infiltration (thick arrow), lymphocytes penetrate into the hepatocytes (thin arrow), and rose cluster hepatocytes (arrow), ×200.

  1. Ethics statement: Ethics Statement is not applicable for the case report according to the Medical Ethics Committee of the Third Hospital of Zhenjiang Affiliated Jiangsu University, but Informed consent was obtained from the patient for publication of this case report and accompanying images. The study was conducted in accordance with the Declaration of Helsinki.

3 Discussion

HAV is a globally prevalent infectious agent causing intestinal disease. It is mainly transmitted by the fecal-oral route, usually developing as an acute infection followed by self-recovery [1]. HAV-IgM is indicative evidence of an active HAV infection. It appears one week after HAV infection and generally lasts for 3–6 months. HAV-IgM has rarely been detected beyond 1 year [2,3]. Compared to HAV RNA detection, HAV-IgM detection is convenient and fast. It is the primary indicator of current infection with HAV, especially in endemic areas. The accuracy of anti-HAV IgM testing is comparable to HAV RNA detection in the diagnosis of acute hepatitis A [4]. In the absence of a hepatitis A outbreak, a disadvantage of the HAV RNA RT-PCR assay is its high cost as it is not a routine investigation in our country, nor in most other countries. Conversely, it has the advantage of being able to detect acute hepatitis A in its early stages, especially during a hepatitis A epidemic [5]. This will prove to be of great significance to control the further spread of the disease. Another limitation of the HAV RNA assay is that it is susceptible to environmental contamination and is not a genuine test for the HAV virus. However, HAV RNA can be present in the blood for a long time (mean: 79 days) and has also been reported to be present for more than 1 year [6].

The HAV vaccine was included in China’s immunization program from 2008. With the universal vaccination of children, the reported incidence of HAV in China has decreased significantly, from 7.34/100,000 in 2004 to 1.66/100,000 in 2015, thus indicating that the prevalence of HAV has been controlled [7]. HAV-RNA is no longer used as a routine diagnostic test having been replaced by the more convenient and cheaper method of IgM antibody testing. In countries where HAV outbreaks are under control, real cases of HAV are rare. For example, in the United States, 10,735 HAV-IgM samples were collected from Kansas City, Missouri, from January 2007 to December 2010. Among them, 49 HAV-IgM positive test results were found in 35 patients. Finally, only 4 patients were detected with acute HAV (11%) [8]. In conclusion, in areas where HAV is controlled, the diagnosis of acute HAV infection should take into account a comprehensive analysis of epidemic history, clinical characteristics, and laboratory examination [9]. Testing HAV-IgM in individuals with asymptomatic infection or with no history of epidemic disease is not recommended [10]. An investigative report shows that the Department of Health and the Centers for Disease Control and Prevention in the United States conducted a survey on individuals with HAV-IgM positivity from 2002 to 2004 [6]. Those who did not meet the clinical criteria for the case were defined as HAV. The report shows that most of the positive test results did not represent a recent, acute HAV infection. In order to improve the predictive value of positive HAV-IgM detection, clinicians should limit laboratory detection of acute HAV infection to those with typical clinical manifestations or those who have been exposed to suspected hepatitis infection in an environment favoring transmission.

The false-positive IgM mechanism is complex and is the result of comprehensive factors, such as polyclonal B cell activation [11,12], vigorous immune response [11,12], influenza vaccination [13], cross-reactive antibodies [14,15,16], autoimmune disease [17], heterologous reactions to similar viruses [18,19,20], subclinical reactivation of latent viruses [21], interfering substances (e.g., rheumatoid factor) [22,23], and naturally occurring biotin IgM antibodies [24]. In addition to the above, cutoff values being set too low [25,26], faulty reagents [27], technical errors (e.g., overreading weakly reactive bands on immunoblots) [28], low pretest probability [8], and inappropriate testing [6,8] also affect the results.

Although a false-positive HAV-IgM should be common in areas where hepatitis A has been controlled, there is a lack of sizeable data based on population surveys. Our search on PubMed, EMBAS, Web of science, and other databases, using the keywords “False-positive HAV-IgM,” or “False-positive hepatitis A IgM,” revealed a total of 3 cases, with a false-positive HAV-IgM and related conditions [17,29,30]. Two cases of false-positive HAV-IgM were associated with AIH [17,29]; Table 1.

Table 1

False-positive HAV-IgM cases reported

Case Country Age Sex True etiology LFT Immunologic test False HAV-IgM Potential impact Report
1 Australia 54 F Idiopathic scleritis;DILI by infliximab ALT, 829 U/L; AST, 554 U/L IgG, 18.4 g/L; IgM, 5.71 g/L; ANA), 1:640 Measured on 2 occasions Infliximab treatment was discontinued, biochemical improvement within 11 weeks Elaine Tennant [17]
1 USA 78 F Congestive heart failure Mildly abnormal liver enzyme levels, which resolved as her CHF was treated N/A Low index, twice the cutoff Public health investigation, exclusion from adult daycare center Marie Louise Landry [30]
1 Switzerland 38 F Autoimmune hepatitis and EBV infection ALT,424 U/L; AST, 244 U/L ANA ≥ 1:320; SMA ≥ 1:80 Three times were detected, HAVIgM (+, +, −); HAVIgG (+, −, −) N/A Marika Valota [29]

False positives for IgM usually occur under three circumstances. First, diseases with similar clinical presentation, such as infectious mononucleosis, CMV infection, EBV infection, human immunodeficiency virus infection [16,19,20], rubella, measles [31,32], hepatitis A, and hepatitis E viral infection [12,33,34]. However, false positives of HAV-IgM caused by CMV, EBV, and HIV are still reported in individual cases, and the mechanism is thought to be an immune cross-reaction. For example, EBV and HAV may induce autologous production of antibodies against triosephosphate isomerase (IgM anti-TPI)) [35]. Abnormal autoantibody-induced immune damage can lead to hemolysis.

Secondly, when there is an overlap with the etiology of other diseases. Finally, IgM positivity with no corresponding clinical symptoms, biochemical indicators, or histological evidence.

False-positive IgM results can lead to a disproportionate response in the prevention and control of infectious disease, thus delaying the treatment of the original disease. This patient was diagnosed with acute HAV, and this attracted the attention of the disease control department. The residence was disinfected, and the patient was forcibly hospitalized in isolation. This inconvenienced both, her work and her life, in addition to mental trauma. Simultaneously, the treatment of AIH was also delayed to a certain extent. The same confusion was seen in other case reports. A 76-year-old woman with congestive heart failure was diagnosed as having HAV by a community doctor in view of a positive HAV-IgM test, which resulted in her being barred from living in the community [30]. False-positive HAV-IgM leads to misdiagnosis of the original condition, leading to the failure of timely and correct diagnosis and treatment of the primary disease. For example, in this case, corticosteroid therapy was used to control the disease until AIH was confirmed by liver histological examination. In China, if liver function is abnormal, especially if liver enzyme levels are elevated, hepatologists often prescribe dicyclol and other drugs, which have been proven to be beneficial for liver inflammation repair, improvement of fibrosis, and alleviation of liver enzymes [36,37]. Although these drugs are yet to be validated in prospective, randomized, controlled, multicenter studies, no significant side effects have been found with these drugs. Some patients use Chinese herbs, including Schisandra fruit and Chuangcao, to protect the liver [38,39]. These herbs have also been shown to be beneficial for treating liver diseases.

Therefore, even though a positive HAV-IgM test forms the basis for the diagnosis of acute HAV, it should not be accepted as the only confirmatory test, especially when results persist, the patient’s condition is severe enough to require hospitalization, or when there are no epidemiological findings. Instead, wherever possible, the diagnosis should be confirmed by other means.


tel: +86-13914567088, fax: +86-511-88970796

Appendix

Table A1

Changes of main indexes of liver function and immunoglobulin G

Time (w) TBIL (mol/L) ALT (U/L) AST (U/L) ALP (U/L) GGT (U/L) IgG (g/L)
0 8.3 56 45 109 65 18.3
1 12.7 131.2 89 97 49
4 7.8 104 77 115 64
20 11.7 86 48 142 90 21.6
36 5.4 147 112 108 57
48 13.5 123 94 142 59 26.3
49 21.7 327 227 128 86
50 43 572 554 175 112
51 32.5 164.4 107 118 89 19.5
52 12.6 137.1 84 97 57
56 11.7 86.4 56 115 49
60 10.6 35.2 28 138 63 13.8
64 8.5 31.6 22 96 38
68 10.7 28.6 18 69 36
72 9.4 25.2 23 79 47 8.5

W: week; TIL: total bilirubin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: glutamine transpeptidase.

  1. Funding information: No funding was received.

  2. Author contributions: Y.W. Tan designed the research; L. Chen collected and analyzed the data, and drafted the manuscript; Y.W. Tan wrote and revised the manuscript; all authors have read and approved the final version to be published.

  3. Conflict of interest: The authors declare that they have no conflict of interest.

  4. Data availability statement: The data of the study are available from the corresponding author on reasonable request.

References

[1] Lemon SM , Ott JJ , Van Damme P , Shouval D . Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol. 2017 Sep 5;68:167–84.10.1016/j.jhep.2017.08.034Search in Google Scholar PubMed

[2] Bower WA , Nainan OV , Han X , Margolis HS . Duration of viremia in hepatitis A virus infection. J Infect Dis. 2000 Jul;182(1):12–7.10.1086/315701Search in Google Scholar PubMed

[3] Cohen JI , Feinstone S , Purcell RH . Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs. J Infect Dis. 1989 Nov;160(5):887–90.10.1093/infdis/160.5.887Search in Google Scholar PubMed

[4] Lemon SM . Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clin Chem. 1997 Aug;43(8 Pt 2):1494–9.10.1093/clinchem/43.8.1494Search in Google Scholar

[5] Cuthbert JA . Hepatitis A: old and new. Clin Microbiol Rev. 2001 Jan;14(1):38–58.10.1128/CMR.14.1.38-58.2001Search in Google Scholar PubMed PubMed Central

[6] Centers for Disease C, Prevention. Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis – United States, 2002–2004. Morb Mortal Wkly Rep. 2005 May 13;54(18):453–6.Search in Google Scholar

[7] Sun X , Wang F , Zheng H , Miao N , Yuan Q , Cui F , et al. The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004–2016. Vaccine. 2018 Feb 28;36(10):1279–84.10.1016/j.vaccine.2018.01.043Search in Google Scholar PubMed

[8] Alatoom A , Ansari MQ , Cuthbert J . Multiple factors contribute to positive results for hepatitis A virus immunoglobulin M antibody. Arch Pathol Lab Med. 2013 Jan;137(1):90–5.10.5858/arpa.2011-0693-OASearch in Google Scholar PubMed

[9] Nainan OV , Xia G , Vaughan G , Margolis HS . Diagnosis of hepatitis a virus infection: a molecular approach. Clin Microbiol Rev. 2006 Jan;19(1):63–79.10.1128/CMR.19.1.63-79.2006Search in Google Scholar PubMed PubMed Central

[10] Desai AN , Kim AY . Management of hepatitis A in 2020–2021. JAMA. 2020 Jul 28;324(4):383–84.10.1001/jama.2020.4017Search in Google Scholar PubMed

[11] Woods CR . False-positive results for immunoglobulin M serologic results: explanations and examples. J Pediatric Infect Dis Soc. 2013 Mar;2(1):87–90.10.1093/jpids/pis133Search in Google Scholar PubMed

[12] Sakiani S , Koh C , Heller T . Understanding the presence of false-positive antibodies in acute hepatitis. J Infect Dis. 2014 Dec 15;210(12):1886–9.10.1093/infdis/jiu348Search in Google Scholar

[13] Mac Kenzie WR , Davis JP , Peterson DE , Hibbard AJ , Becker G , Zarvan BS . Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991. JAMA. 1992 Aug 26;268(8):1015–7.10.1001/jama.268.8.1015Search in Google Scholar

[14] Asnis DS , Conetta R , Teixeira AA , Waldman G , Sampson BA . The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis. 2000 Mar;30(3):413–8.10.1086/313737Search in Google Scholar

[15] Centers for Disease C, Prevention. Human Jamestown canyon virus infection – Montana, 2009. Morb Mortal Wkly Rep. 2011 May 27;60(20):652–5.Search in Google Scholar

[16] Hyams C , Mabayoje DA , Copping R , Maranao D , Patel M , Labbett W , et al. Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection. J Med Virol. 2014 Mar;86(3):478–83.10.1002/jmv.23827Search in Google Scholar

[17] Tennant E , Post JJ . Production of false-positive immunoglobulin M antibodies to hepatitis A virus in autoimmune events. J Infect Dis. 2016 Jan 15;213(2):324–5.10.1093/infdis/jiv417Search in Google Scholar

[18] Sohn MJ , Cho JM , Moon JS , Ko JS , Yang HREBV . VCA IgM and cytomegalovirus IgM dual positivity is a false positive finding related to age and hepatic involvement of primary Epstein-Barr virus infection in children. Medicine (Baltimore). 2018 Sep;97(38):e12380.10.1097/MD.0000000000012380Search in Google Scholar

[19] Post JJ , Chan MK , Whybin LR , Shi Q , Rawlinson WD , Cunningham P , et al. Positive Epstein-Barr virus and cytomegalovirus IgM assays in primary HIV infection. J Med Virol. 2011 Aug;83(8):1406–9.10.1002/jmv.22109Search in Google Scholar

[20] Just-Nubling G , Korn S , Ludwig B , Stephan C , Doerr HW , Preiser W . Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Infection. 2003 Oct;31(5):318–23.10.1007/s15010-003-3129-ySearch in Google Scholar

[21] Aalto SM , Linnavuori K , Peltola H , Vuori E , Weissbrich B , Schubert J , et al. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol. 1998 Nov;56(3):186–91.10.1002/(SICI)1096-9071(199811)56:3<186::AID-JMV2>3.0.CO;2-3Search in Google Scholar

[22] Meurman OH , Ziola BR . IgM-class rheumatoid factor interference in the solid-phase radioimmunoassay of rubella-specific IgM antibodies. J Clin Pathol. 1978 May;31(5):483–7.10.1136/jcp.31.5.483Search in Google Scholar

[23] Bartels EM , Ribel-Madsen S . Cytokine measurements and possible interference from heterophilic antibodies--problems and solutions experienced with rheumatoid factor. Methods. 2013 May 15;61(1):18–22.10.1016/j.ymeth.2012.12.015Search in Google Scholar PubMed

[24] Chen T , Hedman L , Mattila PS , Jartti L , Jartti T , Ruuskanen O , et al. Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays. PLoS One. 2012;7(8):e42376.10.1371/journal.pone.0042376Search in Google Scholar PubMed PubMed Central

[25] Kamata A , Obinata K , Niizuma T , Kinoshita K , Shimizu T . The validity of the criteria for primary infection of Chlamydophila pneumoniae in children by measuring ELISA IgM antibodies. J Infect Chemother. 2012 Jun;18(3):308–12.10.1007/s10156-011-0327-xSearch in Google Scholar PubMed

[26] Prince HE , Lieberman JM . Impact of the Yosemite hantavirus outbreak on hantavirus antibody testing at a national reference laboratory. Clin Vaccine Immunol. 2013 Aug;20(8):1213–6.10.1128/CVI.00326-13Search in Google Scholar PubMed PubMed Central

[27] Centers for Disease C, Prevention. False-positive results with a commercially available West Nile virus immunoglobulin m assay – United States, 2008. Morb Mortal Wkly Rep. 2009 May 8;58(17):458–60.Search in Google Scholar

[28] Seriburi V , Ndukwe N , Chang Z , Cox ME , Wormser GP . High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice. Clin Microbiol Infect. 2012 Dec;18(12):1236–40.10.1111/j.1469-0691.2011.03749.xSearch in Google Scholar PubMed

[29] Valota M , Thienemann F , Misselwitz B . False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection. BMJ Case Rep. 2019 May 10;12:5.10.1136/bcr-2018-228356Search in Google Scholar PubMed PubMed Central

[30] Landry ML . Immunoglobulin M for Acute Infection: True or False. Clin Vaccine Immunol. 2016 Jul;23(7):540–5.10.1128/CVI.00211-16Search in Google Scholar PubMed PubMed Central

[31] Jenkerson SA , Beller M , Middaugh JP , Erdman DD . False positive rubeola IgM tests. N Engl J Med. 1995 Apr 20;332(16):1103–4.10.1056/NEJM199504203321616Search in Google Scholar PubMed

[32] Costa E , Tormo N , Clari MA , Bravo D , Munoz-Cobo B , Navarro D . Performance of the Epstein-Barr virus and herpes simplex virus immunoglobulin m assays on the liaison platform with sera from patients displaying acute parvovirus B19 infection. Clin Vaccine Immunol. 2009 Aug;16(8):1247–8.10.1128/CVI.00142-09Search in Google Scholar PubMed PubMed Central

[33] Lanciotti RS , Kerst AJ , Nasci RS , Godsey MS , Mitchell CJ , Savage HM , et al. Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol. 2000 Nov;38(11):4066–71.10.1128/JCM.38.11.4066-4071.2000Search in Google Scholar PubMed PubMed Central

[34] Jang JH , Jung YM , Kim JS , Lee SH , Kim JW , Hwang SG , et al. Coexistence of IgM antihepatitis A virus and IgM antihepatitis E virus in acute viral hepatitis: a prospective, multicentre study in Korea. J Viral Hepat. 2011 Oct;18(10):e408–14.10.1111/j.1365-2893.2011.01477.xSearch in Google Scholar

[35] Ritter S , Schroder S , Uy A , Ritter K . Haemolysis in hepatitis A virus infections coinciding with the occurrence of autoantibodies against triosephosphate isomerase and the reactivation of latent persistent Epstein-Barr virus infection. J Med Virol. 1996 Nov;50(3):272–5.10.1002/(SICI)1096-9071(199611)50:3<272::AID-JMV10>3.0.CO;2-MSearch in Google Scholar

[36] Hassan A , Fontana RJ . The diagnosis and management of idiosyncratic drug-induced liver injury. Liver Int. 2019 Jan;39(1):31–41.10.1111/liv.13931Search in Google Scholar

[37] Katarey D , Verma S . Drug-induced liver injury. Clin Med (Lond). 2016 Dec;16(Suppl 6):s104–9.10.7861/clinmedicine.16-6-s104Search in Google Scholar

[38] Zhu P , Li J , Fu X , Yu Z . Schisandra fruits for the management of drug-induced liver injury in China: a review. Phytomedicine. 2019 Jun;59:152760.10.1016/j.phymed.2018.11.020Search in Google Scholar

[39] Li Z , He X , Liu F , Wang J , Feng J . A review of polysaccharides from Schisandra chinensis and Schisandra sphenanthera: Properties, functions and applications. Carbohydr Polym. 2018 Mar 15;184:178–90.10.1016/j.carbpol.2017.12.058Search in Google Scholar

Received: 2021-05-30
Revised: 2021-07-19
Accepted: 2021-07-22
Published Online: 2021-09-07

© 2021 Youwen Tan and Li Chen, published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Identification of ZG16B as a prognostic biomarker in breast cancer
  3. Behçet’s disease with latent Mycobacterium tuberculosis infection
  4. Erratum
  5. Erratum to “Suffering from Cerebral Small Vessel Disease with and without Metabolic Syndrome”
  6. Research Articles
  7. GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway
  8. Expression and role of ABIN1 in sepsis: In vitro and in vivo studies
  9. Additional baricitinib loading dose improves clinical outcome in COVID-19
  10. The co-treatment of rosuvastatin with dapagliflozin synergistically inhibited apoptosis via activating the PI3K/AKt/mTOR signaling pathway in myocardial ischemia/reperfusion injury rats
  11. SLC12A8 plays a key role in bladder cancer progression and EMT
  12. LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
  13. Case Report
  14. Serratia marcescens as a cause of unfavorable outcome in the twin pregnancy
  15. Spleno-adrenal fusion mimicking an adrenal metastasis of a renal cell carcinoma: A case report and embryological background
  16. Research Articles
  17. TRIM25 contributes to the malignancy of acute myeloid leukemia and is negatively regulated by microRNA-137
  18. CircRNA circ_0004370 promotes cell proliferation, migration, and invasion and inhibits cell apoptosis of esophageal cancer via miR-1301-3p/COL1A1 axis
  19. LncRNA XIST regulates atherosclerosis progression in ox-LDL-induced HUVECs
  20. Potential role of IFN-γ and IL-5 in sepsis prediction of preterm neonates
  21. Rapid Communication
  22. COVID-19 vaccine: Call for employees in international transportation industries and international travelers as the first priority in global distribution
  23. Case Report
  24. Rare squamous cell carcinoma of the kidney with concurrent xanthogranulomatous pyelonephritis: A case report and review of the literature
  25. An infertile female delivered a baby after removal of primary renal carcinoid tumor
  26. Research Articles
  27. Hypertension, BMI, and cardiovascular and cerebrovascular diseases
  28. Case Report
  29. Coexistence of bilateral macular edema and pale optic disc in the patient with Cohen syndrome
  30. Research Articles
  31. Correlation between kinematic sagittal parameters of the cervical lordosis or head posture and disc degeneration in patients with posterior neck pain
  32. Review Articles
  33. Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
  34. Research Articles
  35. Thermography in the diagnosis of carpal tunnel syndrome
  36. Pemetrexed-based first-line chemotherapy had particularly prominent objective response rate for advanced NSCLC: A network meta-analysis
  37. Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
  38. The influence of smoking in minimally invasive spinal fusion surgery
  39. Impact of body mass index on left atrial dimension in HOCM patients
  40. Expression and clinical significance of CMTM1 in hepatocellular carcinoma
  41. miR-142-5p promotes cervical cancer progression by targeting LMX1A through Wnt/β-catenin pathway
  42. Comparison of multiple flatfoot indicators in 5–8-year-old children
  43. Early MRI imaging and follow-up study in cerebral amyloid angiopathy
  44. Intestinal fatty acid-binding protein as a biomarker for the diagnosis of strangulated intestinal obstruction: A meta-analysis
  45. miR-128-3p inhibits apoptosis and inflammation in LPS-induced sepsis by targeting TGFBR2
  46. Dynamic perfusion CT – A promising tool to diagnose pancreatic ductal adenocarcinoma
  47. Biomechanical evaluation of self-cinching stitch techniques in rotator cuff repair: The single-loop and double-loop knot stitches
  48. Review Articles
  49. The ambiguous role of mannose-binding lectin (MBL) in human immunity
  50. Case Report
  51. Membranous nephropathy with pulmonary cryptococcosis with improved 1-year follow-up results: A case report
  52. Fertility problems in males carrying an inversion of chromosome 10
  53. Acute myeloid leukemia with leukemic pleural effusion and high levels of pleural adenosine deaminase: A case report and review of literature
  54. Metastatic renal Ewing’s sarcoma in adult woman: Case report and review of the literature
  55. Burkitt-like lymphoma with 11q aberration in a patient with AIDS and a patient without AIDS: Two cases reports and literature review
  56. Skull hemophilia pseudotumor: A case report
  57. Judicious use of low-dosage corticosteroids for non-severe COVID-19: A case report
  58. Adult-onset citrullinaemia type II with liver cirrhosis: A rare cause of hyperammonaemia
  59. Clinicopathologic features of Good’s syndrome: Two cases and literature review
  60. Fatal immune-related hepatitis with intrahepatic cholestasis and pneumonia associated with camrelizumab: A case report and literature review
  61. Research Articles
  62. Effects of hydroxyethyl starch and gelatin on the risk of acute kidney injury following orthotopic liver transplantation: A multicenter retrospective comparative clinical study
  63. Significance of nucleic acid positive anal swab in COVID-19 patients
  64. circAPLP2 promotes colorectal cancer progression by upregulating HELLS by targeting miR-335-5p
  65. Ratios between circulating myeloid cells and lymphocytes are associated with mortality in severe COVID-19 patients
  66. Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
  67. Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China
  68. Surgical myocardial revascularization outcomes in Kawasaki disease: systematic review and meta-analysis
  69. Decreased chromobox homologue 7 expression is associated with epithelial–mesenchymal transition and poor prognosis in cervical cancer
  70. FGF16 regulated by miR-520b enhances the cell proliferation of lung cancer
  71. Platelet-rich fibrin: Basics of biological actions and protocol modifications
  72. Accurate diagnosis of prostate cancer using logistic regression
  73. miR-377 inhibition enhances the survival of trophoblast cells via upregulation of FNDC5 in gestational diabetes mellitus
  74. Prognostic significance of TRIM28 expression in patients with breast carcinoma
  75. Integrative bioinformatics analysis of KPNA2 in six major human cancers
  76. Exosomal-mediated transfer of OIP5-AS1 enhanced cell chemoresistance to trastuzumab in breast cancer via up-regulating HMGB3 by sponging miR-381-3p
  77. A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer
  78. Knockdown of circ_0003204 alleviates oxidative low-density lipoprotein-induced human umbilical vein endothelial cells injury: Circulating RNAs could explain atherosclerosis disease progression
  79. Propofol postpones colorectal cancer development through circ_0026344/miR-645/Akt/mTOR signal pathway
  80. Knockdown of lncRNA TapSAKI alleviates LPS-induced injury in HK-2 cells through the miR-205/IRF3 pathway
  81. COVID-19 severity in relation to sociodemographics and vitamin D use
  82. Clinical analysis of 11 cases of nocardiosis
  83. Cis-regulatory elements in conserved non-coding sequences of nuclear receptor genes indicate for crosstalk between endocrine systems
  84. Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
  85. Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens
  86. Relation between IL-8 level and obstructive sleep apnea syndrome
  87. circAGFG1 sponges miR-28-5p to promote non-small-cell lung cancer progression through modulating HIF-1α level
  88. Nomogram prediction model for renal anaemia in IgA nephropathy patients
  89. Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
  90. NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
  91. A nomogram for predicting metabolic steatohepatitis: The combination of NAMPT, RALGDS, GADD45B, FOSL2, RTP3, and RASD1
  92. Clinical and prognostic features of MMP-2 and VEGF in AEG patients
  93. The value of miR-510 in the prognosis and development of colon cancer
  94. Functional implications of PABPC1 in the development of ovarian cancer
  95. Prognostic value of preoperative inflammation-based predictors in patients with bladder carcinoma after radical cystectomy
  96. Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
  97. Prediction of improvement after anterior cruciate ligament reconstruction
  98. Effluent Osteopontin levels reflect the peritoneal solute transport rate
  99. circ_0038467 promotes PM2.5-induced bronchial epithelial cell dysfunction
  100. Significance of miR-141 and miR-340 in cervical squamous cell carcinoma
  101. Association between hair cortisol concentration and metabolic syndrome
  102. Microvessel density as a prognostic indicator of prostate cancer: A systematic review and meta-analysis
  103. Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
  104. Knee alterations in rheumatoid arthritis: Comparison of US and MRI
  105. Long non-coding RNA TUG1 aggravates cerebral ischemia and reperfusion injury by sponging miR-493-3p/miR-410-3p
  106. lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p
  107. Development and validation of a nomogram for predicting severity in patients with hemorrhagic fever with renal syndrome: A retrospective study
  108. Analysis of COVID-19 outbreak origin in China in 2019 using differentiation method for unusual epidemiological events
  109. Laparoscopic versus open major liver resection for hepatocellular carcinoma: A case-matched analysis of short- and long-term outcomes
  110. Travelers’ vaccines and their adverse events in Nara, Japan
  111. Association between Tfh and PGA in children with Henoch–Schönlein purpura
  112. Can exchange transfusion be replaced by double-LED phototherapy?
  113. circ_0005962 functions as an oncogene to aggravate NSCLC progression
  114. Circular RNA VANGL1 knockdown suppressed viability, promoted apoptosis, and increased doxorubicin sensitivity through targeting miR-145-5p to regulate SOX4 in bladder cancer cells
  115. Serum intact fibroblast growth factor 23 in healthy paediatric population
  116. Algorithm of rational approach to reconstruction in Fournier’s disease
  117. A meta-analysis of exosome in the treatment of spinal cord injury
  118. Src-1 and SP2 promote the proliferation and epithelial–mesenchymal transition of nasopharyngeal carcinoma
  119. Dexmedetomidine may decrease the bupivacaine toxicity to heart
  120. Hypoxia stimulates the migration and invasion of osteosarcoma via up-regulating the NUSAP1 expression
  121. Long noncoding RNA XIST knockdown relieves the injury of microglia cells after spinal cord injury by sponging miR-219-5p
  122. External fixation via the anterior inferior iliac spine for proximal femoral fractures in young patients
  123. miR-128-3p reduced acute lung injury induced by sepsis via targeting PEL12
  124. HAGLR promotes neuron differentiation through the miR-130a-3p-MeCP2 axis
  125. Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
  126. Cell population data in identifying active tuberculosis and community-acquired pneumonia
  127. Prognostic value of microRNA-4521 in non-small cell lung cancer and its regulatory effect on tumor progression
  128. Mean platelet volume and red blood cell distribution width is associated with prognosis in premature neonates with sepsis
  129. 3D-printed porous scaffold promotes osteogenic differentiation of hADMSCs
  130. Association of gene polymorphisms with women urinary incontinence
  131. Influence of COVID-19 pandemic on stress levels of urologic patients
  132. miR-496 inhibits proliferation via LYN and AKT pathway in gastric cancer
  133. miR-519d downregulates LEP expression to inhibit preeclampsia development
  134. Comparison of single- and triple-port VATS for lung cancer: A meta-analysis
  135. Fluorescent light energy modulates healing in skin grafted mouse model
  136. Silencing CDK6-AS1 inhibits LPS-induced inflammatory damage in HK-2 cells
  137. Predictive effect of DCE-MRI and DWI in brain metastases from NSCLC
  138. Severe postoperative hyperbilirubinemia in congenital heart disease
  139. Baicalin improves podocyte injury in rats with diabetic nephropathy by inhibiting PI3K/Akt/mTOR signaling pathway
  140. Clinical factors predicting ureteral stent failure in patients with external ureteral compression
  141. Novel H2S donor proglumide-ADT-OH protects HUVECs from ox-LDL-induced injury through NF-κB and JAK/SATA pathway
  142. Triple-Endobutton and clavicular hook: A propensity score matching analysis
  143. Long noncoding RNA MIAT inhibits the progression of diabetic nephropathy and the activation of NF-κB pathway in high glucose-treated renal tubular epithelial cells by the miR-182-5p/GPRC5A axis
  144. Serum exosomal miR-122-5p, GAS, and PGR in the non-invasive diagnosis of CAG
  145. miR-513b-5p inhibits the proliferation and promotes apoptosis of retinoblastoma cells by targeting TRIB1
  146. Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p
  147. The diagnostic and prognostic value of miR-92a in gastric cancer: A systematic review and meta-analysis
  148. Prognostic value of α2δ1 in hypopharyngeal carcinoma: A retrospective study
  149. No significant benefit of moderate-dose vitamin C on severe COVID-19 cases
  150. circ_0000467 promotes the proliferation, metastasis, and angiogenesis in colorectal cancer cells through regulating KLF12 expression by sponging miR-4766-5p
  151. Downregulation of RAB7 and Caveolin-1 increases MMP-2 activity in renal tubular epithelial cells under hypoxic conditions
  152. Educational program for orthopedic surgeons’ influences for osteoporosis
  153. Expression and function analysis of CRABP2 and FABP5, and their ratio in esophageal squamous cell carcinoma
  154. GJA1 promotes hepatocellular carcinoma progression by mediating TGF-β-induced activation and the epithelial–mesenchymal transition of hepatic stellate cells
  155. lncRNA-ZFAS1 promotes the progression of endometrial carcinoma by targeting miR-34b to regulate VEGFA expression
  156. Anticoagulation is the answer in treating noncritical COVID-19 patients
  157. Effect of late-onset hemorrhagic cystitis on PFS after haplo-PBSCT
  158. Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma
  159. VSTM1 regulates monocyte/macrophage function via the NF-κB signaling pathway
  160. Comparison of vaginal birth outcomes in midwifery-led versus physician-led setting: A propensity score-matched analysis
  161. Treatment of osteoporosis with teriparatide: The Slovenian experience
  162. New targets of morphine postconditioning protection of the myocardium in ischemia/reperfusion injury: Involvement of HSP90/Akt and C5a/NF-κB
  163. Superenhancer–transcription factor regulatory network in malignant tumors
  164. β-Cell function is associated with osteosarcopenia in middle-aged and older nonobese patients with type 2 diabetes: A cross-sectional study
  165. Clinical features of atypical tuberculosis mimicking bacterial pneumonia
  166. Proteoglycan-depleted regions of annular injury promote nerve ingrowth in a rabbit disc degeneration model
  167. Effect of electromagnetic field on abortion: A systematic review and meta-analysis
  168. miR-150-5p affects AS plaque with ASMC proliferation and migration by STAT1
  169. MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p
  170. Effects of remifentanil and propofol on distant organ lung injury in an ischemia–reperfusion model
  171. miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway
  172. Identification of LIG1 and LIG3 as prognostic biomarkers in breast cancer
  173. MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy
  174. Dissecting role of founder mutation p.V727M in GNE in Indian HIBM cohort
  175. circATP2A2 promotes osteosarcoma progression by upregulating MYH9
  176. Prognostic role of oxytocin receptor in colon adenocarcinoma
  177. Review Articles
  178. The function of non-coding RNAs in idiopathic pulmonary fibrosis
  179. Efficacy and safety of therapeutic plasma exchange in stiff person syndrome
  180. Role of cesarean section in the development of neonatal gut microbiota: A systematic review
  181. Small cell lung cancer transformation during antitumor therapies: A systematic review
  182. Research progress of gut microbiota and frailty syndrome
  183. Recommendations for outpatient activity in COVID-19 pandemic
  184. Rapid Communication
  185. Disparity in clinical characteristics between 2019 novel coronavirus pneumonia and leptospirosis
  186. Use of microspheres in embolization for unruptured renal angiomyolipomas
  187. COVID-19 cases with delayed absorption of lung lesion
  188. A triple combination of treatments on moderate COVID-19
  189. Social networks and eating disorders during the Covid-19 pandemic
  190. Letter
  191. COVID-19, WHO guidelines, pedagogy, and respite
  192. Inflammatory factors in alveolar lavage fluid from severe COVID-19 pneumonia: PCT and IL-6 in epithelial lining fluid
  193. COVID-19: Lessons from Norway tragedy must be considered in vaccine rollout planning in least developed/developing countries
  194. What is the role of plasma cell in the lamina propria of terminal ileum in Good’s syndrome patient?
  195. Case Report
  196. Rivaroxaban triggered multifocal intratumoral hemorrhage of the cabozantinib-treated diffuse brain metastases: A case report and review of literature
  197. CTU findings of duplex kidney in kidney: A rare duplicated renal malformation
  198. Synchronous primary malignancy of colon cancer and mantle cell lymphoma: A case report
  199. Sonazoid-enhanced ultrasonography and pathologic characters of CD68 positive cell in primary hepatic perivascular epithelioid cell tumors: A case report and literature review
  200. Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
  201. Pulmonary parenchymal involvement caused by Tropheryma whipplei
  202. Mediastinal mixed germ cell tumor: A case report and literature review
  203. Ovarian female adnexal tumor of probable Wolffian origin – Case report
  204. Rare paratesticular aggressive angiomyxoma mimicking an epididymal tumor in an 82-year-old man: Case report
  205. Perimenopausal giant hydatidiform mole complicated with preeclampsia and hyperthyroidism: A case report and literature review
  206. Primary orbital ganglioneuroblastoma: A case report
  207. Primary aortic intimal sarcoma masquerading as intramural hematoma
  208. Sustained false-positive results for hepatitis A virus immunoglobulin M: A case report and literature review
  209. Peritoneal loose body presenting as a hepatic mass: A case report and review of the literature
  210. Chondroblastoma of mandibular condyle: Case report and literature review
  211. Trauma-induced complete pacemaker lead fracture 8 months prior to hospitalization: A case report
  212. Primary intradural extramedullary extraosseous Ewing’s sarcoma/peripheral primitive neuroectodermal tumor (PIEES/PNET) of the thoracolumbar spine: A case report and literature review
  213. Computer-assisted preoperative planning of reduction of and osteosynthesis of scapular fracture: A case report
  214. High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib
  215. Rapid response of locally advanced oral squamous cell carcinoma to apatinib: A case report
  216. Retrieval of intrarenal coiled and ruptured guidewire by retrograde intrarenal surgery: A case report and literature review
  217. Usage of intermingled skin allografts and autografts in a senior patient with major burn injury
  218. Retraction
  219. Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
  220. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part I
  221. An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
  222. Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2021-0336/html
Scroll to top button